๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

A randomized Phase II trial in patients with carcinoma of an unknown primary site

โœ Scribed by Jonathan E. Dowell; Audrey M. Garrett; Yu Shyr; David H. Johnson; Kenneth R. Hande

Publisher
John Wiley and Sons
Year
2001
Tongue
English
Weight
79 KB
Volume
91
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

A Phase II trial of nolatrexed dihydroch
A Phase II trial of nolatrexed dihydrochloride in patients with advanced hepatocellular carcinoma
โœ Keith Stuart; Judy Tessitore; Jeff Rudy; Neil Clendennin; Amanda Johnston ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 70 KB ๐Ÿ‘ 2 views

## BACKGROUND. Inoperable hepatocellular carcinoma is an incurable malignancy with no accepted standard therapy. Chemotherapy has demonstrated occasional responses and the need is great for a new and effective agent. Therefore the authors conducted this Phase II trial of a novel thymidylate syntha

A Phase II trial of high dose epirubicin
A Phase II trial of high dose epirubicin in patients with advanced breast carcinoma
โœ Kathy D. Miller; Nikhil Munshi; David Loesch; Lawrence H. Einhorn; George W. Sle ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 82 KB ๐Ÿ‘ 2 views

## BACKGROUND. Anthracyclines are among the most active drugs in the treatment of breast carcinoma and exhibit a steep dose-response curve in vitro. This trial was performed to determine the efficacy and toxicity of epirubicin in the treatment of patients with advanced breast carcinoma when adminis